Skip to main content

Table 1 Patient and tumor characteristics

From: Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer

Clinicopathologic features

n = 25 (%)

Median age (years)

75

Age range

42–81

Sex

 Male

18 (72)

 Female

7 (28)

Tumor location

 Pancreas head

20 (80)

 Pancreas body & tail

5 (20)

T stage

 T1 – T2

7 (28)

 T3

18 (72)

N status

 N0

12 (48)

 N1–2

13 (52)

R status

 R0

19 (76)

 R1

5 (20)

 Rx

1 (4)

Lymphovascular invasion

 L0

15 (60)

 L1

10 (40)

Perineural invasion

 Pn0

2 (8)

 Pn1

23 (92)

Grading

 G2

13 (52)

 G3

12 (48)

Adjuvant chemotherapy

 Yes

17 (68)

 No

8 (32)

Time to relapse (months)

 Median

10

 Range

0.5–42

Overall survival (months)

 Median

22

 Range

0.5–46